Position in INSM
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,254,799
+$712,308 QoQ
Shares Held
21,148
+97.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#276
of 663 holders
Holding Since
Sep 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qsemble Capital Management, LP holds $7,848,553 across 6 Biotechnology names. INSM ranks #2 (28.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
31,633 | $2,356,025 | |
| 2 | INSM |
INSMED Inc
This page
|
21,148 | $2,254,799 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
47,971 | $1,871,348 | |
| 4 | RPRX |
Royalty Pharma plc
|
10,675 | $598,547 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
5,639 | $459,634 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
3,887 | $308,200 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,254,799 | 21,148 | Shares | Sole | 2026-08-03 | |
| 2025-09-30 | $1,542,491 | 10,711 | Shares | Sole | 2025-11-13 | |
| 2024-09-30 | $1,690,315 | 23,155 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||